Commercial Applications
Surnetics’ microfluidics patent portfolio addresses six high-growth application areas in life science, diagnostics, and medical devices. Each represents an active market where corporate IP buyers are acquiring and licensing foundational technology.
Point-of-Care Diagnostics
Our microfluidics IP portfolio includes patents directly applicable to point-of-care (POC) testing devices. Miniaturized fluid handling, integrated sample preparation, and on-chip detection methods enable rapid diagnostic tests outside the central laboratory.
Passive flow eliminates the pump hardware that drives cost and complexity in cartridge-reader systems — reducing bill-of-materials by 80%+ and enabling truly battery-free test formats for resource-limited settings.
Abbott Diagnostics, Roche, bioMérieux, Siemens Healthineers, Becton Dickinson
Molecular Diagnostics & PCR
Lab-on-a-chip architectures within this portfolio support nucleic acid amplification, including PCR and isothermal amplification. Passive fluid routing enables precise sample delivery to reaction chambers without external fluidic pressure sources or pumps.
Applications include pathogen detection, genetic screening, liquid biopsy, and next-generation sequencing (NGS) sample prep. Controlled, repeatable flow profiles improve assay sensitivity and reduce reagent consumption.
Thermo Fisher Scientific, Qiagen, Hologic, Meridian Bioscience, GenMark Diagnostics
Immunoassays & Biosensing
Microfluidic immunoassay platforms reduce reagent consumption and turnaround time versus traditional ELISA. Our patents covering flow control, surface functionalization, and detection chamber design are directly relevant to lateral flow assay manufacturers and electrochemical biosensor developers.
The ability to engineer precise flow velocities and passive stop/start zones enables multi-step immunoassay protocols with no active timing control — dramatically simplifying device architecture.
Abbott, Siemens Healthineers, Roche Diagnostics, bioMérieux, Luminex
Drug Delivery & Nanoparticle Synthesis
Microfluidic synthesis of lipid nanoparticles (LNPs), polymeric nanoparticles, and drug-loaded microcapsules is a rapidly growing application of lab-on-a-chip technology. Our IP covering passive fluid mixing and controlled flow profiles supports pharmaceutical companies developing mRNA delivery platforms or targeted cancer therapeutics.
Precise flow control at microfluidic scales enables tighter nanoparticle size distributions and higher encapsulation efficiencies than bulk mixing processes.
Pfizer, Moderna, AstraZeneca, Evonik, Precision NanoSystems
Clinical Laboratory Automation
High-throughput sample processing, parallel microfluidic operations, and automated fluid routing are covered within this patent portfolio. Applicable to clinical chemistry analyzers, automated immunoassay systems, and next-generation sequencing (NGS) sample prep workflows.
Passive microfluidic routing eliminates solenoid valves and pneumatic control systems, reducing instrument complexity and enabling a new class of sample preparation modules.
Danaher (Beckman Coulter, Cepheid), Bio-Rad, Sysmex, Ortho Clinical Diagnostics
Wearable & Continuous Monitoring
Miniaturized microfluidic architectures suitable for wearable biosensors enable continuous monitoring of biomarkers from sweat, interstitial fluid, or blood. Passive flow control — requiring no pump or battery-driven fluidics — is a fundamental enabling technology for truly wearable, disposable sensor patches.
Applications include glucose monitoring, electrolyte tracking, metabolite sensing, and performance monitoring for sports, military, and clinical remote patient monitoring.
Abbott (FreeStyle Libre), Dexcom, Medtronic, Philips, Biolinq
We offer outright sale, exclusive license, non-exclusive license, and field-of-use licensing structures. Contact us to discuss which model fits your organization.
Inquire About Licensing